Pseudomonas aeruginosa Bacteremia Associated with Hematologic Disorders

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: A

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae

BACKGROUND This study was performed to detect risk factors for Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis. METHODS A retrospective case-control study was designed to identify risk factors for P. aeruginosa bacteremia in cirrhotic patients. The cases were cirrhotic patients with P. aeruginosa bacteremia and the controls were cirrhotic patients with Enterobacteriaceae ba...

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

Trends of rising rates of resistance in Pseudomonas aeruginosa make selection of appropriate empirical therapy increasingly difficult, but whether multidrug-resistant (MDR) P. aeruginosa is associated with worse clinical outcomes is not well established. The objective of this study was to determine the impact of MDR (resistance to three or more classes of antipseudomonal agents) P. aeruginosa b...

Incidence of Pseudomonas aeruginosa bacteremia: a population-based study.

BACKGROUND The incidence of Pseudomonas aeruginosa bacteremia has not been defined in a population-based investigation. METHODS We performed a retrospective, population-based incidence study using resources of the Rochester Epidemiology Project of Olmsted County, Minnesota. We identified all Olmsted County residents with P. aeruginosa bacteremia between January 1, 1997, and December 31, 2006,...